Abbott accelerates PFA market competition in Europe with early Volt approval

By Yahoo! Finance   |   1 month ago
Abbott accelerates PFA market competition in Europe with early Volt approval

Abbott's Volt system receives CE marking for PFA treatment of atrial fibrillation, entering the competitive EU market. The technology offers precise and safe tissue ablation with promising clinical trial results, challenging existing medtech players in a growing market exceeding $500m.

Read More

Did you find this insightful?